These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 10210787

  • 1. Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS.
    Calista D, Boschini A, Landi G.
    Eur J Dermatol; 1999; 9(3):211-3. PubMed ID: 10210787
    [Abstract] [Full Text] [Related]

  • 2. Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined antiretroviral therapy with saquinavir, zidovudine and lamivudine.
    Hurni MA, Böhlen L, Furrer H, Braathen LR.
    AIDS; 1997 Nov 15; 11(14):1784-5. PubMed ID: 9386818
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
    Monpoux F, Sirvent N, Cottalorda J, Mariani R, Lefbvre JC.
    AIDS; 1997 Oct 15; 11(12):1523-5. PubMed ID: 9342078
    [No Abstract] [Full Text] [Related]

  • 5. [Erosive and budding molluscum contagiosum: total regression under antiretroviral therapy].
    Koudoukpo C, Yédomon GH, Adégbidi H, Atadokpédé F, Do Ango-Padonou F.
    Ann Dermatol Venereol; 2012 Mar 15; 139(3):225-7. PubMed ID: 22401692
    [No Abstract] [Full Text] [Related]

  • 6. [HIV-therapy: as early and as intensive as possible].
    Dtsch Med Wochenschr; 1997 Oct 10; 122(41):A27. PubMed ID: 9378051
    [No Abstract] [Full Text] [Related]

  • 7. Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient.
    Tachikawa N, Yasuoka A, Oka S.
    Jpn J Infect Dis; 1999 Dec 10; 52(6):245-6. PubMed ID: 10738363
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM, Chêuc G, Ferchal F, Journot V, Pellegrin I, Sombardier MN, Rancinan C, Cotte L, Madelaine I, Debord T, Decazes JM, ALBI (ANRS 070) Study Group.
    Antivir Ther; 1999 Dec 10; 4 Suppl 3():71-4. PubMed ID: 16021874
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients.
    de Mendoza C, Soriano V, Pérez-Olmeda M, Rodríguez-Rosado R, González-Lahoz J.
    J Hum Virol; 2000 Dec 10; 3(6):335-40. PubMed ID: 11100914
    [Abstract] [Full Text] [Related]

  • 13. [Drug combination therapy for children infected with HIV/AIDS--own experience].
    Prandota-Schoepp A, Klinowska-Skupniewska J.
    Przegl Epidemiol; 2001 Dec 10; 55 Suppl 3():135-41. PubMed ID: 11984940
    [Abstract] [Full Text] [Related]

  • 14. HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients.
    Quirino T, Niero F, Ricci E, Pusterla L, Carradori S, Gabbuti A, Iemoli E, Landonio S, Faggion I, Bonfanti P, CISAI study group. Italian Coordination for the Study HIV Infection and Allergies.
    Antivir Ther; 2000 Sep 10; 5(3):195-7. PubMed ID: 11075939
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
    Eiros Bouza JM, Ortega Lafont M, Ortiz de Lejarazu R, Bachiller Luque P, de Luis Román DA.
    An Med Interna; 2003 May 10; 20(5):239-42. PubMed ID: 12831297
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Diagnosis and treatment of ocular viral infections in AIDS patients].
    Guex-Crosier Y.
    Rev Med Suisse Romande; 1998 Nov 10; 118(11):941-7. PubMed ID: 9865123
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar 10; 14(4):367-74. PubMed ID: 10770538
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.